Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Incidence and Burden of the Myelodysplastic Syndromes

    ... therapy with hypomethlating agents (azacitidine and decitabine ) carry a poor prognosis.  These patients may be considered for ...

    Research Review last updated 05/02/2016 - 9:11am.

  2. Therapies

    ... U.S. to treat MDS. Azacitidine (Vidaza®) and decitabine (Dacogen®) are approved to treat both low- and high-risk ...

    Page last updated 03/18/2016 - 11:26am.

  3. Myelodysplastic syndromes: What do hospitalists need to know?

    ... agents such as azacitidine (Vidaza®) and decitabine (Dacogen®), intensive chemotherapy, and stem cell transplantation.  Patients tend to tolerate azacitidine and decitabine fairly well.  These agents appear to restore normal cell production ...

    Research Review last updated 05/02/2016 - 9:21am.

  4. Treatments

    ... U.S. to treat MDS. Azacitidine (Vidaza®) and decitabine (Dacogen®) are approved to treat both low- and high-risk ...

    Topic section last updated 03/30/2016 - 3:13pm.

  5. Clinical Trial Basics

    ... bone marrow failure diseases. These include: decitabine (Dacogen) deferasirox (Exjade) ...

    Page last updated 03/29/2016 - 7:29pm.

  6. FAQs

    ... currently include lenalidomide (Revlimid), decitabine (Dacogen) and azacitidine (Vidaza). Chemotherapy ... These include lenalidomide (Revlimid®) decitabine (Dacogen®) and azacitidine (Vidaza®). Learn more about ...

    Topic section last updated 03/02/2016 - 11:42am.

  7. A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ... Associated Drug(s):  Decitabine Phase:  ... administered orally and continuously for 28 days. Drug: Decitabine Decitabine given at 20 mg/m2 over 1 hour infusion for 5-days Drug: ...

    Clinical Trial last updated 04/27/2016 - 9:27am.

  8. Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant (ICT-HCT)

    ... Azacitidine Decitabine Phase:  ... Hydrochloride Rubilem Drug: Decitabine Given IV or SC Other Names: 5-Aza-2'-deoxycytidine Dacogen Decitabine for Injection Deoxyazacytidine Dezocitidine Drug: ...

    Clinical Trial last updated 04/27/2016 - 9:41am.

  9. MDS - Treatment (OLD)

    ... U.S. These include azacitidine (Vidaza®) and decitabine (Dacogen®), both considered hypomethylating agents, and ...

    Topic section last updated 03/10/2016 - 11:01pm.

  10. Clinical Trials Report for January 2016

    ... Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS) This 2-stage, ...

    Page last updated 01/07/2016 - 10:57am.